Literature DB >> 29781342

DW-MRI and DCE-MRI are of complementary value in predicting pathologic response to neoadjuvant chemoradiotherapy for esophageal cancer.

Sophie E Heethuis1, Lucas Goense1,2, Peter S N van Rossum1, Alicia S Borggreve1,2, Stella Mook1, Francine E M Voncken3, Annemarieke Bartels-Rutten4, Berthe M P Aleman3, Richard van Hillegersberg2, Jelle P Ruurda2, Gert J Meijer1, Jan J W Lagendijk1, Astrid L H M W van Lier1.   

Abstract

PURPOSE: To explore the potential benefit and complementary value of a multiparametric approach using diffusion-weighted (DW-) and dynamic contrast-enhanced (DCE-) magnetic resonance imaging (MRI) for prediction of response to neoadjuvant chemoradiotherapy (nCRT) in esophageal cancer.
MATERIAL AND METHODS: Forty-five patients underwent both DW-MRI and DCE-MRI prior to nCRT (pre), during nCRT (week 2-3) (per) and after completion of nCRT, but prior to esophagectomy (post). Subsequently, histopathologic tumor regression grade (TRG) was assessed. Tumor apparent diffusion coefficient (ADC) and area-under-the-concentration time curve (AUC) were calculated for DW-MRI and DCE-MRI, respectively. The ability of these parameters to predict pathologic complete response (pCR, TRG1) or good response (GR, TRG ≤ 2) to nCRT was assessed. Furthermore the complementary value of DW-MRI and DCE-MRI was investigated.
RESULTS: GR was found in 22 (49%) patients, of which 10 (22%) patients showed pCR. For DW-MRI, the 75th percentile (P75) ΔADCpost-pre was most predictive for GR (c-index = 0.75). For DCE-MRI, P90 ΔAUCper-pre was most predictive for pCR (c-index = 0.79). Multivariable logistic regression analyses showed complementary value when combining DW-MRI and DCE-MRI for pCR prediction (c-index = 0.89).
CONCLUSIONS: Both DW-MRI and DCE-MRI are promising in predicting response to nCRT in esophageal cancer. Combining both modalities provides complementary information, resulting in a higher predictive value.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29781342     DOI: 10.1080/0284186X.2018.1473637

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  16 in total

1.  Clinical response assessment on DW-MRI compared with FDG-PET/CT after neoadjuvant chemoradiotherapy in patients with oesophageal cancer.

Authors:  Sophie E Vollenbrock; Francine E M Voncken; Doenja M J Lambregts; Monique Maas; Maarten L Donswijk; Erik Vegt; Leon C Ter Beek; Jolanda M van Dieren; Johanna W van Sandick; Berthe M P Aleman; Regina G H Beets-Tan; Annemarieke Bartels-Rutten
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-06-22       Impact factor: 9.236

Review 2.  Towards an Organ-Sparing Approach for Locally Advanced Esophageal Cancer.

Authors:  Berend Jan van der Wilk; Ben M Eyck; Manon C W Spaander; Roelf Valkema; Sjoerd M Lagarde; Bas P L Wijnhoven; J Jan B van Lanschot
Journal:  Dig Surg       Date:  2018-09-18       Impact factor: 2.588

3.  Surveillance of Clinically Complete Responders Using Serial 18F-FDG PET/CT Scans in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy.

Authors:  Maria J Valkema; Berend J van der Wilk; Ben M Eyck; Bas P L Wijnhoven; Manon C W Spaander; Michail Doukas; Sjoerd M Lagarde; Wendy M J Schreurs; Mark J Roef; J Jan B van Lanschot; Roelf Valkema
Journal:  J Nucl Med       Date:  2020-09-04       Impact factor: 11.082

Review 4.  How rapid advances in imaging are defining the future of precision radiation oncology.

Authors:  Laura Beaton; Steve Bandula; Mark N Gaze; Ricky A Sharma
Journal:  Br J Cancer       Date:  2019-03-26       Impact factor: 7.640

5.  Exploratory radiomic features from integrated 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging are associated with contemporaneous metastases in oesophageal/gastroesophageal cancer.

Authors:  Serena Baiocco; Bert-Ram Sah; Andrew Mallia; Christian Kelly-Morland; Radhouene Neji; J James Stirling; Sami Jeljeli; Alessandro Bevilacqua; Gary J R Cook; Vicky Goh
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-03-27       Impact factor: 9.236

Review 6.  Quantitative Magnetic Resonance Imaging for Biological Image-Guided Adaptive Radiotherapy.

Authors:  Petra J van Houdt; Yingli Yang; Uulke A van der Heide
Journal:  Front Oncol       Date:  2021-01-29       Impact factor: 6.244

7.  Review of MR-Guided Radiotherapy for Esophageal Cancer.

Authors:  Sangjune Laurence Lee; Michael Bassetti; Gert J Meijer; Stella Mook
Journal:  Front Oncol       Date:  2021-03-22       Impact factor: 6.244

8.  ASO Author Reflections: Predicting Early Recurrence After Trimodality Therapy for Esophageal Adenocarcinoma.

Authors:  Lucas Goense; Steven H Lin
Journal:  Ann Surg Oncol       Date:  2018-11-15       Impact factor: 5.344

9.  Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer.

Authors:  Alicia S Borggreve; Sophie E Heethuis; Mick R Boekhoff; Lucas Goense; Peter S N van Rossum; Lodewijk A A Brosens; Astrid L H M W van Lier; Richard van Hillegersberg; Jan J W Lagendijk; Stella Mook; Jelle P Ruurda; Gert J Meijer
Journal:  Eur Radiol       Date:  2019-12-10       Impact factor: 5.315

10.  DCE-MRI Quantitative Parameters as Predictors of Treatment Response in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Underwent CCRT.

Authors:  Bing Liu; Zhen Sun; Wan-Ling Ma; Jing Ren; Guang-Wen Zhang; Meng-Qi Wei; Wei-Huan Hou; Bing-Xin Hou; Li-Chun Wei; Yi Huan; Min-Wen Zheng
Journal:  Front Oncol       Date:  2020-10-29       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.